Merus N.V.
MRUS
$96.14
$0.150.15%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
12/3/2025
-
Globe Newswire
12/3/2025
-
MarketBeat
12/2/2025
-
Tickeron - Stocks
11/29/2025
-
MarketBeat
11/29/2025
-
MarketBeat
11/28/2025
-
Ticker Report
11/28/2025
-
Simply Wall St
11/27/2025
-
Simply Wall St
11/26/2025
-
Simply Wall St
11/26/2025
-
Tickeron - Stocks
11/25/2025
-
Seeking Alpha - Long Ideas
11/25/2025
-
SeekingAlpha
11/23/2025
-
MarketBeat
11/22/2025
-
Globe Newswire
11/22/2025
-
Tickeron - Stocks
11/21/2025
-
PR Newswire
11/21/2025
-
MarketBeat
11/19/2025
-
Simply Wall St
11/18/2025
-
Simply Wall St
11/18/2025
-
MarketBeat
11/17/2025
-
Nasdaq News: Markets
11/17/2025
-
GuruFocus
11/17/2025
-
GuruFocus
11/17/2025
-
The Fly
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, October 31, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Feb 23 and 27 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
31 30 253 8800
Address
Uppsalalaan 17
Utrecht, 3584 CT
Utrecht, 3584 CT
Country
Year Founded
Business Description
Sector
Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes BIZENGRI for the...
more